iShares Biotechnology ETF - WKN 657791, ISIN US4642875565

Ex-Date	Pay Date	Amount	Change
2025		$0.204
16/09/2025	19/09/2025	$0.0828	-31.68%
18/03/2025	21/03/2025	$0.1212	94.23%
2024		$0.3888	11.76%
17/12/2024	20/12/2024	$0.0624	-68.88%
25/09/2024	30/09/2024	$0.2005	59.13%
21/03/2024	27/03/2024	$0.126	1.61%
2023		$0.3479	-14.75%
20/12/2023	27/12/2023	$0.124	-19.06%
26/09/2023	02/10/2023	$0.1532	2,370.97%
07/06/2023	13/06/2023	$0.0062	-90.4%
23/03/2023	29/03/2023	$0.0646	-36.29%
2022		$0.4081	27.53%
13/12/2022	19/12/2022	$0.1014	-36.07%
26/09/2022	30/09/2022	$0.1586	420%
09/06/2022	15/06/2022	$0.0305	-74.06%
24/03/2022	30/03/2022	$0.1176	184.75%
2021		$0.32	2.99%
13/12/2021	17/12/2021	$0.0413	-66.8%
24/09/2021	30/09/2021	$0.1244	436.21%
10/06/2021	16/06/2021	$0.0232	-82.3%
25/03/2021	31/03/2021	$0.1311	100.15%
2020		$0.3107	48.66%
14/12/2020	18/12/2020	$0.0655	3.64%
23/09/2020	29/09/2020	$0.0632	-50.04%
15/06/2020	19/06/2020	$0.1265	128.34%
25/03/2020	31/03/2020	$0.0554	-4.15%
2019		$0.209	10.93%
16/12/2019	20/12/2019	$0.0578	-19.16%
24/09/2019	30/09/2019	$0.0715	-10.29%
17/06/2019	21/06/2019	$0.0797	145.99%
2018		$0.1884	-73.83%
26/09/2018	02/10/2018	$0.0324	-79.24%
26/06/2018	02/07/2018	$0.1561	24.48%
2017		$0.7199	46.11%
21/12/2017	28/12/2017	$0.1254	5.64%
26/09/2017	29/09/2017	$0.1187	-32.86%
27/06/2017	30/06/2017	$0.1768	-40.87%
24/03/2017	30/03/2017	$0.299	225.35%
2016		$0.4927	433.23%
22/12/2016	29/12/2016	$0.0919	7.11%
26/09/2016	30/09/2016	$0.0858	-47.1%
21/06/2016	27/06/2016	$0.1622	6.15%
23/03/2016	30/03/2016	$0.1528	377.5%
2015		$0.0924	-79.33%
24/12/2015	31/12/2015	$0.032	1,180%
25/09/2015	01/10/2015	$0.0025	-95.69%
24/06/2015	30/06/2015	$0.058	7.61%

Date	Ratio
01/12/2017	3:1

iShares Biotechnology ETF pays a dividend yield (FWD) of 0.25%.

14 Countries: United States
94.47%
Denmark
1.97%
United Kingdom
1.01%
Netherlands
0.97%
Switzerland
0.47%
Canada
0.37%
China
0.17%
Italy
0.11%
Australia
0.11%
Spain
0.096%
Singapore
0.093%
Germany
0.068%
Belgium
0.046%
Ireland
0.040%
1 Sector: Health Care
100.00%
240 Holdings: Amgen Inc7.69%
Gilead Sciences Inc7.66%
Vertex Pharmaceuticals Inc7.46%
Regeneron Pharmaceuticals Inc6.01%
Alnylam Pharmaceuticals Inc5.03%
Insmed Inc3.49%
argenx SE ADR3.33%
IQVIA Holdings Inc3.23%
Mettler-Toledo International Inc2.68%
Natera Inc2.39%
Aristocrats see all 240 holdings

Resources

Similar securities

Security	Div.%	Div.CAGR 5Y	Div.Freq.	Sector	Type
Invesco FTSE Emerging Markets High Dividend Low Volatility UCITS ETFAd	5.02%	-1.59%	quarterly	mixed	ETF
Rio Tinto PLC	5.45%	#.##%	biannually	Materials	Equity
iShares STOXX Global Select Dividend 100 UCITS ETF (DE)	4.64%	#.##%	quarterly	mixed	ETF
Deutsche Lufthansa AG	4.01%	#.##%	annually	Industrials	Equity
Infineon Technologies AG	1.06%	#.##%	annually	Information Technology	Equity
Abbott Laboratories	1.87%	#.##%	quarterly	Health Care	Equity
Wirecard AG	-	#.##%	none	Information Technology	Equity
Danone SA	2.75%	#.##%	annually	Consumer Staples	Equity
iShares Swiss Dividend ETF (CH)	3.62%	#.##%	quarterly	mixed	ETF
Vanguard S&P 500 ETF	1.13%	#.##%	quarterly	mixed	ETF